Find policies, billing codes, payers, states, and providers
CPT 93701: Cardiac Bioimpedance Study
CPT code 93701 represents a bioimpedance study used to assess cardiovascular physiology by measuring thoracic impedance and deriving parameters related to heart function and fluid status. Nationally, this diagnostic test is relevant for cardiology services that evaluate heart performance, manage heart failure, and monitor fluid balance. The code is used across outpatient diagnostic centers and hospital cardiology labs and factors into utilization, billing workflows, and coverage determinations.
Key payers included in the analysis are Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of clinical context for the procedure, typical sites of service, and what to expect in payer coverage considerations. The publication summarizes benchmarks for utilization and reimbursement, highlights policy updates affecting diagnostic cardiovascular testing, and outlines clinical scenarios in which a bioimpedance study may be documented. The content is intended for billing professionals, clinical administrators, and policy analysts seeking concise guidance on coding, billing, and the role of this diagnostic test in care pathways.
Data not available in the input: associated taxonomies, specific ICD-10 diagnoses, related codes, and detailed payer-specific coverage rules.
Customize your policy alerts
Sign up for cpt 93701 policy alerts
Get alerted when payer policies referencing 93701 are released or updated.
Monitor payer policy activity
Billing Code Overview
CPT code 93701 describes a bioimpedance study of cardiovascular function. The procedure measures thoracic bioimpedance to estimate physiological cardiac parameters that aid evaluation of cardiovascular status and fluid dynamics.
Service Type: Diagnostic cardiovascular testing
Typical Site of Service: Outpatient diagnostic facility or hospital-based cardiology lab